Skip to content

Opening book details…

Can I read Targeting the glucocorticoid receptor signature gene Mono Amine Oxidase-A enhances the efficacy of chemo- and anti-androgen therapy in advanced prostate cancer on EtoBox?

Targeting the glucocorticoid receptor signature gene Mono Amine Oxidase-A enhances the efficacy of chemo- and anti-androgen therapy in advanced prostate cancer by Martin Puhr; Andrea Eigentler; Florian Handle; Hubert Hackl; Christian Ploner; Isabel Heidegger; Georg Schaefer; Maximilian P. Brandt; Julia Hoefer; Gabri Van der Pluijm; Helmut Klocker is a Biochemistry, Genetics and Molecular Biology article available to read on EtoBox.

What is Targeting the glucocorticoid receptor signature gene Mono Amine Oxidase-A enhances the efficacy of chemo- and anti-androgen therapy in advanced prostate cancer about?

Despite increasing options for treatment of castration-resistant prostate cancer, development of drug resistance is inevitable. The glucocorticoid receptor (GR) is a prime suspect for acquired therapy resistance, as prostate cancer (PCa) cells are able to increase GR signaling during anti-androgen therapy and thereby circumvent androgen receptor (AR)-blockade and cell death. As standard AR-directed therapies fail to block the GR and GR inhibitors might result in intolerable side effects, the identification of GR signature genes, which are better suited for a targeted approach, is of clinical importance. Therefore, the specific epithelial and stromal GR signature was determined in cancer-associated fibroblasts as well as in abiraterone and enzalutamide-resistant cells after glucocorticoid (GC) treatment. Microarray and ChIP analysis identified MAO-A as a directly up-regulated mutual epithelial and stromal GR target, which is induced after GC treatment and during PCa progression. Elevated MAO-A levels were confirmed in in vitro cell models, in primary tissue cultures after GC treatment, and in patients after neoadjuvant chemotherapy with GCs. MAO-A expression correlates with GR/AR ac

Who reads Targeting the glucocorticoid receptor signature gene Mono Amine Oxidase-A enhances the efficacy of chemo- and anti-androgen therapy in advanced prostate cancer?

It is typically read by researchers, students, and practitioners in Biochemistry, Genetics and Molecular Biology.

Author
Martin Puhr; Andrea Eigentler; Florian Handle; Hubert Hackl; Christian Ploner; Isabel Heidegger; Georg Schaefer; Maximilian P. Brandt; Julia Hoefer; Gabri Van der Pluijm; Helmut Klocker
Publisher
Springer Science and Business Media LLC
Published
2021
Language
EN
Field
Biochemistry, Genetics and Molecular Biology (Life Sciences)

More by Martin Puhr; Andrea Eigentler; Florian Handle; Hubert Hackl; Christian Ploner; Isabel Heidegger; Georg Schaefer; Maximilian P. Brandt; Julia Hoefer; Gabri Van der Pluijm; Helmut Klocker

Browse all works by Martin Puhr; Andrea Eigentler; Florian Handle; Hubert Hackl; Christian Ploner; Isabel Heidegger; Georg Schaefer; Maximilian P. Brandt; Julia Hoefer; Gabri Van der Pluijm; Helmut Klocker